Abstract
Sarcopenia, the age-dependent loss of muscle mass and function, is a common condition among older adults, and is associated with several adverse health outcomes. Owing to the impact of sarcopenia on quality of life, disability and mortality, a greater awareness is necessary in order to correctly identify the condition both in community and geriatric settings. Research on sarcopenia prevention and treatment is developing quickly, but many questions are still unanswered. The core of the sarcopenia condition involves quantitative and qualitative losses of skeletal muscle. These two dimensions should therefore be considered when designing and testing preventive and therapeutic interventions. The recently released operationalization of sarcopenia by the Foundation for the National Institutes of Health (FNIH) Sarcopenia Project allows for the framing of an objective, standardized, and clinically relevant condition, which should facilitate its translation into the clinical arena as well as its adoption by public health and regulatory agencies. Such a conceptualization might eventually encourage key stakeholders to combine their efforts in approaching the sarcopenia condition. Bearing these considerations in mind, the “Sarcopenia and Physical fRailty IN older people: multi-componenT Treatment strategies” project has operationalized a specific condition, named physical frailty and sarcopenia (PF&S), characterized by the combination of low physical performance (based on the Short Physical Performance Battery) and low muscle mass (according to the FNIH cut-points). A randomized controlled trial will be conducted to evaluate the efficacy of a multi-component intervention for preventing mobility disability and other adverse health outcomes in older adults with PF&S.
Similar content being viewed by others
References
Rosenberg IH (1997) Sarcopenia: origins and clinical relevance. J Nutr 127:990 S–991 S
Cruz-Jentoft AJ, Landi F, Topinková E, Michel JP (2010) Understanding sarcopenia as a geriatric syndrome. Curr Opin Clin Nutr Metab Care 13:1–7. doi:10.1097/MCO.0b013e328333c1c1
Reginster JY, Cooper C, Rizzoli R, Kanis JA, Appelboom G, Bautmans I, Bischoff-Ferrari HA, Boers M, Brandi ML, Bruyère O, Cherubini A, Flamion B, Fielding RA, Gasparik AI, Van Loon L, McCloskey E, Mitlak BH, Pilotto A, Reiter-Niesert S, Rolland Y, Tsouderos Y, Visser M, Cruz-Jentoft AJ (2016) Recommendations for the conduct of clinical trials for drugs to treat or prevent sarcopenia. Aging Clin Exp Res 28:47–58. doi:10.1007/s40520-015-0517-y
Cruz-Jentoft AJ, Landi F (2014) Sarcopenia. Clin Med 14:183–186. doi:10.7861/clinmedicine.14-2-183
Grimby G, Saltin B (1983) The ageing muscle. Clin Physiol 3:209–218. doi:10.1111/j.1475-097X.1983.tb00704.x
Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinková E, Vandewoude M, Zamboni M, European Working Group on Sarcopenia in Older People (2010) Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 39:412–423. doi:10.1093/ageing/afq034
Cruz-Jentoft AJ, Landi F, Schneider SM, Zúñiga C, Arai H, Boirie Y, Chen LK, Fielding RA, Martin FC, Michel JP, Sieber C, Stout JR, Studenski SA, Vellas B, Woo J, Zamboni M, Cederholm T (2014) Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing 43:748–759. doi:10.1093/ageing/afu115
Goodpaster BH, Park SW, Harris TB, Kritchevsky SB, Nevitt M, Schwartz AV, Simonsick EM, Tylavsky FA, Visser M, Newman AB (2006) The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci 61:1059–1064
Newman AB, Kupelian V, Visser M, Simonsick EM, Goodpaster BH, Kritchevsky SB, Tylavsky FA, Rubin SM, Harris TB (2006) Strength, but not muscle mass, is associated with mortality in the health, aging and body composition study cohort. J Gerontol A Biol Sci Med Sci 61:72–77
Kim YH, Kim KI, Paik NJ, Kim KW, Jang HC, Lim JY (2015) Muscle strength: a better index of low physical performance than muscle mass in older adults. Geriatr Gerontol Int 16:577–585. doi:10.1111/ggi.12514
Clark BC, Manini TM (2012) What is dynapenia? Nutrition 28:495–503. doi:10.1016/j.nut.2011.12.002
Srikanthan P, Karlamangla AS (2014) Muscle mass index as a predictor of longevity in older adults. Am J Med 127:547–553. doi:10.1016/j.amjmed.2014.02.007
Chuang SY, Chang HY, Lee MS, Chia-Yu Chen R, Pan WH (2014) Skeletal muscle mass and risk of death in an elderly population. Nutr Metab Cardiovasc Dis 24:784–791. doi:10.1016/j.numecd.2013.11.010
Marzetti E, Lees HA, Wohlgemuth SE, Leeuwenburgh C (2009) Sarcopenia of aging: underlying cellular mechanisms and protection by calorie restriction. Biofactors 35:28–35. doi:10.1002/biof.5
Landi F, Calvani R, Tosato M, Martone AM, Ortolani E, Savera G, D’Angelo E, Sisto A, Marzetti E (2016) Protein intake and muscle health in old age: from biological plausibility to clinical evidence. Nutrients 8:5. doi:10.3390/nu8050295
Calvani R, Miccheli A, Landi F, Bossola M, Cesari M, Leewenburgh C, Sieber CC, Bernabei R, Marzetti E (2013) Current nutritional recommendations and novel dietary strategies to manage sarcopenia. J Frailty Aging 2:38–53
Martone AM, Lattanzio F, Abbatecola AM, Carpia DL, Tosato M, Marzetti E, Calvani R, Onder G, Landi F (2015) Treating sarcopenia in older and oldest old. Curr Pharm Des 21:1715–1722. doi:10.2174/1381612821666150130122032
Calvani R, Marini F, Cesari M, Tosato M, Anker SD, von Haehling S, Miller RR, Bernabei R, Landi F, Marzetti E, SPRINTT consortium (2015) Biomarkers for physical frailty and sarcopenia: state of the science and future developments. J Cachexia Sarcopenia Muscle 6:278–286. doi:10.1002/jcsm.12051
Landi F, Marzetti E, Liperoti R, Pahor M, Russo A, Martone AM, Colloca G, Capoluongo E, Bernabei R (2013) Nonsteroidal anti-inflammatory drug (NSAID) use and sarcopenia in older people: results from the ilSIRENTE study. J Am Med Dir Assoc 14:626.e9-13. doi:10.1016/j.jamda.2013.04.012
Marzetti E, Calvani R, Cesari M, Buford TW, Lorenzi M, Behnke BJ, Leeuwenburgh C (2013) Mitochondrial dysfunction and sarcopenia of aging: from signaling pathways to clinical trials. Int J Biochem Cell Biol 45:2288–2301. doi:10.1016/j.biocel.2013.06.024
Calvani R, Martone AM, Marzetti E, Onder G, Savera G, Lorenzi M, Serafini E, Bernabei R, Landi F (2014) Pre-hospital dietary intake correlates with muscle mass at the time of fracture in older hip-fractured patients. Front Aging Neurosci 6:269. doi:10.3389/fnagi.2014.00269
Landi F, Marzetti E, Martone AM, Bernabei R, Onder G (2014) Exercise as a remedy for sarcopenia. Curr Opin Clin Nutr Metab Care 17:25–31. doi:10.1097/MCO.0000000000000018
Landi F, Liperoti R, Fusco D, Mastropaolo S, Quattrociocchi D, Proia A, Tosato M, Bernabei R, Onder G (2012) Sarcopenia and mortality among older nursing home residents. J Am Med Dir Assoc 13:121–126. doi:10.1016/j.jamda.2011.07.004
Landi F, Cruz-Jentoft AJ, Liperoti R, Russo A, Giovannini S, Tosato M, Capoluongo E, Bernabei R, Onder G (2013) Sarcopenia and mortality risk in frail older persons aged 80 years and older: results from ilSIRENTE study. Age Ageing 42:203–209. doi:10.1093/ageing/afs194
Cerri AP, Bellelli G, Mazzone A, Pittella F, Landi F, Zambon A, Annoni G (2015) Sarcopenia and malnutrition in acutely ill hospitalized elderly: prevalence and outcomes. Clin Nutr 34:745–751. doi:10.1016/j.clnu.2014.08.015
Vetrano DL, Landi F, Volpato S, Corsonello A, Meloni E, Bernabei R, Onder G (2014) Association of sarcopenia with short- and long-term mortality in older adults admitted to acute care wards: results from the CRIME study. J Gerontol A Biol Sci Med Sci 69:1154–1161. doi:10.1093/gerona/glu034
Du Y, Karvellas CJ, Baracos V, Williams DC, Khadaroo RG, Acute Care and Emergency Surgery (ACES) Group (2014) Sarcopenia is a predictor of outcomes in very elderly patients undergoing emergency surgery. Surgery 156:521–527. doi:10.1016/j.surg.2014.04.027
Batsis JA, Mackenzie TA, Barre LK, Lopez-Jimenez F, Bartels SJ (2014) Sarcopenia, sarcopenic obesity and mortality in older adults: results from the National Health and Nutrition Examination Survey III. Eur J Clin Nutr 68:1001–1007. doi:10.1038/ejcn.2014.117
Landi F, Liperoti R, Russo A, Giovannini S, Tosato M, Capoluongo E, Bernabei R, Onder G (2012) Sarcopenia as a risk factor for falls in elderly individuals: results from the ilSIRENTE study. Clin Nutr 31:652–658. doi:10.1016/j.clnu.2012.02.007
Ferrucci L, Russo CR, Lauretani F, Bandinelli S, Guralnik JM (2002) A role for sarcopenia in late-life osteoporosis. Aging Clin Exp Res 14:1–4. doi:10.1007/BF03324410
Tarantino U, Baldi J, Celi M, Rao C, Liuni FM, Iundusi R, Gasbarra E (2013) Osteoporosis and sarcopenia: the connections. Aging Clin Exp Res 25S1:S93–S95. doi:10.1007/s40520-013-0097-7
Drey M, Sieber CC, Bertsch T, Bauer JM, Schmidmaier R, FiAT intervention group (2016) Osteosarcopenia is more than sarcopenia and osteopenia alone. Aging Clin Exp Res 28:895–899. doi:10.1007/s40520-015-0494-1
Di Monaco M, Castiglioni C, De Toma E, Gardin L, Giordano S, Di Monaco R, Tappero R (2015) Presarcopenia and sarcopenia in hip-fracture women: prevalence and association with ability to function in activities of daily living. Aging Clin Exp Res 27:465–472. doi:10.1007/s40520-014-0306-z
Coin A, Sarti S, Ruggiero E, Giannini S, Pedrazzoni M, Minisola S, Rossini M, Del Puente A, Inelmen EM, Manzato E, Sergi G (2013) Prevalence of sarcopenia based on different diagnostic criteria using DEXA and appendicular skeletal muscle mass reference values in an Italian population aged 20 to 80. J Am Med Dir Assoc 14:507–512. doi:10.1016/j.jamda.2013.02.010
Landi F, Martone AM, Calvani R, Marzetti E (2014) Sarcopenia risk screening tool: a new strategy for clinical practice. J Am Med Dir Assoc 15:613–614. doi:10.1016/j.jamda.2014.05.015
Landi F, Russo A, Liperoti R, Pahor M, Tosato M, Capoluongo E, Bernabei R, Onder G (2010) Midarm muscle circumference, physical performance and mortality: results from the aging and longevity study in the Sirente geographic area (ilSIRENTE study). Clin Nutr 29:441–447. doi:10.1016/j.clnu.2009.12.006
Landi F, Onder G, Russo A, Liperoti R, Tosato M, Martone AM, Capoluongo E, Bernabei R (2014) Calf circumference, frailty and physical performance among older adults living in the community. Clin Nutr 33:539–544. doi:10.1016/j.clnu.2013.07.013
Lauretani F, Russo CR, Bandinelli S, Bartali B, Cavazzini C, Di IA, Corsi AM, Rantanen T, Guralnik JM, Ferrucci L (2003) Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol 95:1851–1860. doi:10.1152/japplphysiol.00246.2003
Guralnik JM, Simonsick EM, Ferrucci L, Glynn RJ, Berkman LF, Blazer DG, Scherr PA, Wallace RB (1994) A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol 49:M85–M94. doi:10.1093/geronj/49.2.M85
Working Group on Functional Outcome Measures for Clinical Trials (2008) Functional outcomes for clinical trials in frail older persons: time to be moving. J Gerontol A Biol Sci Med Sci 63:160–164
Cesari M (2011) Role of gait speed in the assessment of older patients. JAMA 305:93–94. doi:10.1001/jama.2010.1970
Landi F, Onder G, Bernabei R (2013) Sarcopenia and diabetes: two sides of the same coin. J Am Med Dir Assoc 14:540–541. doi:10.1016/j.jamda.2013.05.004
Martone AM, Onder G, Vetrano DL, Ortolani E, Tosato M, Marzetti E, Landi F (2013) Anorexia of aging: a modifiable risk factor for frailty. Nutrients 5:4126–4133. doi:10.3390/nu5104126
Landi F, Marzetti E, Bernabei R (2013) Perspective: Protein: what kind, how much, when? J Am Med Dir Assoc 14:66–67. doi:10.1016/j.jamda.2012.09.020
Barillaro C, Liperoti R, Martone AM, Onder G, Landi F (2013) The new metabolic treatments for sarcopenia. Aging Clin Exp Res 25:119–127. doi:10.1007/s40520-013-0030-0
Marzetti E, Calvani R, Landi F, Hoogendijk EO, Fougère B, Vellas B, Pahor M, Bernabei R, Cesari M, SPRINTT Consortium (2015) Innovative medicines initiative: The SPRINTT Project. J Frailty Aging 4:207–208
Bernabei R, Martone AM, Vetrano DL, Calvani R, Landi F, Marzetti E (2014) Frailty, physical frailty, sarcopenia: a new conceptual model. Stud Health Technol Inform 203:78–84
Cesari M, Landi F, Vellas B, Bernabei R, Marzetti E (2014) Sarcopenia and physical frailty: two sides of the same coin. Front Aging Neurosci 6:192. doi:10.3389/fnagi.2014.00192
Landi F, Calvani R, Cesari M, Tosato M, Martone AM, Bernabei R, Onder G, Marzetti E (2015) Sarcopenia as the biological substrate of physical frailty. Clin Geriatr Med 31:367–374. doi:10.1016/j.cger.2015.04.005
Studenski SA, Peters KW, Alley DE, Cawthon PM, McLean RR, Harris TB, Ferrucci L, Guralnik JM, Fragala MS, Kenny AM, Kiel DP, Kritchevsky SB, Shardell MD, Dam TT, Vassileva MT (2014) The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci 69:547–558. doi:10.1093/gerona/glu010
Cawthon PM, Peters KW, Shardell MD, McLean RR, Dam TT, Kenny AM, Fragala MS, Harris TB, Kiel DP, Guralnik JM, Ferrucci L, Kritchevsky SB, Vassileva MT, Studenski SA, Alley DE (2014) Cut-points for low appendicular lean mass that identify older adults with clinically significant weakness. J Gerontol A Biol Sci Med Sci 69:567–575. doi:10.1093/gerona/glu023
Acknowledgements
The present work was funded by a grant from the Innovative Medicines Initiative—Joint Undertaking (IMI-JU 115621). The work was also partly supported by the “Centro Studi Achille e Linda Lorenzon” (E.M., R.C.), Fondazione Roma (NCDs Call for Proposals 2013; E.M., R.C.), and intramural research grants from the Catholic University of the Sacred Heart (D3.2 2013 and D3.2 2015; E.M., F.L., R.C.).
Author information
Authors and Affiliations
Consortia
Corresponding authors
Ethics declarations
Conflict of interest
The authors of the present work are partners of the SPRINTT Consortium, which is partly funded by the European Federation of Pharmaceutical Industries and Associations (EFPIA). E.M. served as a consultant for Huron Consulting Group, Genactis, and Novartis. M.C. served as a consultant for and/or received honoraria for scientific presentations from Nestlé.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Informed consent
For this type of study, informed consent is not required.
Rights and permissions
About this article
Cite this article
Marzetti, E., Calvani, R., Tosato, M. et al. Sarcopenia: an overview. Aging Clin Exp Res 29, 11–17 (2017). https://doi.org/10.1007/s40520-016-0704-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40520-016-0704-5